Clinical performance of a novel hybrid IVUS-OCT system: a multicentre, randomised, non-inferiority trial (PANOVISION)
EuroIntervention
.
2023 Jul 17;19(4):e318-e320.
doi: 10.4244/EIJ-D-22-01058.
Authors
Haibo Jia
1
2
,
Chen Zhao
1
2
,
Huai Yu
1
2
,
Zhao Wang
3
,
Huimin Liu
1
2
,
Maoen Xu
1
2
,
Sining Hu
1
2
,
Lulu Li
1
2
,
Luping He
1
2
,
Ziqian Weng
1
2
,
Yuhan Qin
1
2
,
Yishuo Xu
1
2
,
Ming Zeng
1
2
,
Xi Su
4
,
Bin Liu
5
,
Jingbo Hou
1
2
,
Bo Yu
1
2
Affiliations
1
Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
2
The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, People's Republic of China.
3
School of Electronic Science and Engineering, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
4
Department of Cardiology, Wuhan Asia Heart Hospital, Wuhan, People's Republic of China.
5
Department of Cardiology, The Second Hospital of Jilin University, Changchun, People's Republic of China.
PMID:
37057604
PMCID:
PMC10333919
DOI:
10.4244/EIJ-D-22-01058
No abstract available
Publication types
Randomized Controlled Trial
Multicenter Study
MeSH terms
Drug-Eluting Stents*
Humans
Treatment Outcome